China's National Medical Products Administration has approved Hangzhou Aomer Pharmaceutical Co.'s Class 1 innovative drug, sugammadex sodium injection (trade name Aomeikesong), indicated for reversal of rocuronium-induced neuromuscular blockade.

Iran's parliament deputy speaker Babayi vowed to avenge the slain leader and all martyrs in the two conflicts, promising retaliation against the shameless killers.

CETC Chip Technology Co., Ltd. expects H1 2026 net profit attributable to owners of the parent of -¥13.0 mln to -¥10.0 mln, swinging to a loss versus the year-ago period. Adjusted net profit excluding non-recurring items is forecast at -¥31.0 mln to -¥24.0 mln. The company cites a surge in memory prices that weighed on global smartphone volumes and cut revenue from Beidou short-message chips, continued weakness in consumer-electronics demand in its traditional smart-power end markets, and higher metal raw-material and electronic-component costs as the main drivers of the profit decline.